Pneumonia in diseases classified elsewhere Clinical Trials
11 clinical trials for Pneumonia in diseases classified elsewhere across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- COVID19 Chronic Morbidity: Follow-up of patients with COVID19 and non-COVID19 pneumonia with respect to clinical status, pulmonary function and radiologic findings — RECRUITING
- "Medical Vulnerability": Impact of hospital room cooling on vulnerable patients with lung disease during periods of extreme weather (UCaHS) — RECRUITING
- Susceptibility to respiratory tract infections — RECRUITING
- BUrden of Disease and COst of illneSS for RSV and other pathogens in patients 60 years and older within the outpatient setting — OTHER
- Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-PROGRESS) — OTHER
- PROVID-CAPSyS - Systems Medicine of COVID-19, extension Study on PROVID-PROGRESS — OTHER
- Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) — OTHER
- Dental and oral health, oral microbiota, neurological parameters and incidence of pneumonia in acute stroke patients – a prospective observational study — OTHER
- Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ) — OTHER
- Detection of Pneumonia associated Pathogens and Antibiotic Resistance Genes using the Curetis Unyvero® Pneumonia Application — OTHER
- Biomarkers in Cardiology (BIC)-6
Epidemiology: Symptoms and course of disease in the Emergency Room — OTHER
Refine this search